Genetic screening and metabolomics identify glial adenosine metabolism as a therapeutic target in Parkinson's disease.
Sodders MJ, Avila-Pacheco J, Okorie EC, Shen M, Kumari N, Marathi A, Lakhani M, Bullock K, Pierce K, Dennis C, Jeanfavre S, Sarkar S, Scherzer CR, Clish C, Olsen AL.
Sodders MJ, et al.
bioRxiv [Preprint]. 2024 May 15:2024.05.15.594309. doi: 10.1101/2024.05.15.594309.
bioRxiv. 2024.
PMID: 38798570
Free PMC article.
Preprint.